Affordable Access

deepdyve-link
Publisher Website

2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.

Authors
  • Baek, Jong-Suep
  • Cho, Cheong-Weon
Type
Published Article
Journal
The Journal of pharmacy and pharmacology
Publication Date
Jan 01, 2013
Volume
65
Issue
1
Pages
72–78
Identifiers
DOI: 10.1111/j.2042-7158.2012.01578.x
PMID: 23215690
Source
Medline
License
Unknown

Abstract

These results suggest that optimized SLNs modified with 2-hydroxypropyl-β-cyclodextrin may have potential as an oral drug delivery system for PTX.

Report this publication

Statistics

Seen <100 times